Catalyst Pharmaceuticals (CPRX) Cash from Operations Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 60.84% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 85.14% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.72% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 74.39% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.23% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 158.60% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | -0.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.76% |
| Dec 31, 2025 | -36.66% |
| Sep 30, 2025 | -55.49% |
| Jun 30, 2025 | 11.17% |
| Mar 31, 2025 | 88.08% |
| Dec 31, 2024 | 27.37% |
| Sep 30, 2024 | 61.48% |
| Jun 30, 2024 | 108.54% |
| Mar 31, 2024 | 164.50% |
| Dec 31, 2023 | 38.85% |
| Sep 30, 2023 | 9.27% |
| Jun 30, 2023 | 17.42% |
| Mar 31, 2023 | 42.37% |
| Dec 31, 2022 | 109.00% |
| Sep 30, 2022 | 90.27% |
| Jun 30, 2022 | 67.09% |
| Mar 31, 2022 | 122.29% |
| Dec 31, 2021 | 46.33% |
| Sep 30, 2021 | 89.56% |
| Jun 30, 2021 | 18.17% |
| Mar 31, 2021 | -47.12% |
| Dec 31, 2020 | 6.61% |
| Sep 30, 2020 | -29.59% |
| Jun 30, 2020 | -5.75% |
| Mar 31, 2020 | 189.98% |
| Dec 31, 2019 | 247.18% |
| Sep 30, 2019 | 333.90% |
| Jun 30, 2019 | 395.57% |
| Mar 31, 2019 | -31.82% |
| Dec 31, 2018 | -107.24% |
| Sep 30, 2018 | -164.08% |
| Jun 30, 2018 | -48.75% |
| Mar 31, 2018 | -56.78% |
| Dec 31, 2017 | 8.66% |
| Sep 30, 2017 | 19.68% |
| Jun 30, 2017 | 26.30% |
| Mar 31, 2017 | 34.59% |
| Dec 31, 2016 | 4.74% |
| Sep 30, 2016 | 38.65% |
| Jun 30, 2016 | -2.30% |
| Mar 31, 2016 | -56.27% |
| Dec 31, 2015 | -16.37% |
| Sep 30, 2015 | -50.39% |
| Jun 30, 2015 | -42.29% |
| Mar 31, 2015 | -56.49% |
| Dec 31, 2014 | 3.64% |
| Sep 30, 2014 | -110.98% |
| Jun 30, 2014 | -64.65% |
| Mar 31, 2014 | -7.82% |
| Dec 31, 2013 | -159.15% |
| Sep 30, 2013 | -52.96% |
| Jun 30, 2013 | -58.36% |
| Mar 31, 2013 | -72.84% |
| Dec 31, 2012 | -10.82% |
| Sep 30, 2012 | 12.11% |
| Jun 30, 2012 | 21.79% |
| Mar 31, 2012 | -56.57% |
| Dec 31, 2011 | -86.98% |
| Sep 30, 2011 | -53.26% |